Navigation Links
REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body
Date:2/4/2008

rash and/or joint pain.

There have been rare cases of serious liver injury in people taking REMICADE, some fatal. Tell your doctor if you have liver problems and contact your doctor immediately if you develop symptoms such as jaundice (yellow skin and eyes), dark brown urine, right-sided abdominal pain, fever or severe fatigue.

Blood disorders have been reported, some fatal. Tell your doctor if you develop possible signs of blood disorders such as persistent fever, bruising, bleeding or paleness while taking REMICADE. Nervous system disorders have also been reported. Tell your doctor if you have or have had a disease that affects the nervous system, or if you experience any numbness, weakness, tingling, visual disturbances or seizures while taking REMICADE.

Allergic reactions, some severe, have been reported during or after infusions with REMICADE. Signs of an allergic reaction include hives, difficulty breathing, chest pain, high or low blood pressure, swelling of face and hands, and fever or chills. Tell your doctor if you have experienced a severe allergic reaction. The most common side effects of REMICADE are: respiratory infections, such as sinus infections and sore throat, headache, rash, coughing and stomach pain.

Please read the Medication Guide for REMICADE and discuss it with your doctor.

About Centocor

Centocor is harnessing the power of world-leading research and biomanufacturing to deliver innovative biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis.

The world leader in monoclonal antibody production and technology, Centocor has brought critical biologic therapies to patients suffering from debilitating immune disorders.

(i) Reich K, Menter A, et al. Consistency of Infliximab Response Across

Subg
'/>"/>

SOURCE Centocor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents
2. TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
3. JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients
4. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
5. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
6. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
7. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
8. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
10. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
11. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- Advanced wound care - assess products, developments, and ... hold for the advanced wound care market? ... revenues to 2025, assessing data, trends, opportunities and prospects ... 115 tables, charts, and graphs covering 12 distinct submarket ... and the future market prospects. You will see financial ...
(Date:5/6/2015)... 6, 2015  TriStar Wellness Solutions(R), Inc. (OTCQB: ... opportunities in the advanced wound care marketplace, announced ... based wholly owned independent subsidiary HemCon Medical ... the National Institutes of Health (NIH) to develop ... able to be delivered by a catheter to ...
(Date:5/6/2015)... , May 6, 2015 Medizone ... of the AsepticSure® Hospital Disinfection System, have recently ... confirm medical instrument sterilization in autoclaves, may also ... kill for hospital room disinfection. Biological ... can directly monitor the lethality of a given ...
Breaking Medicine Technology:Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 3Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 4Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 5Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 6Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 2Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 3Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 4Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 5Hospital Rooms Cleaned to Autoclave Standards 2
... ANNAPOLIS, Md. , July 30 PharmAthene, Inc. ... developing medical countermeasures against biological and chemical threats, today announced that ... the NYSE Amex LLC, stating that PharmAthene is not in compliance ... (iii) of the NYSE Amex Company Guide, because it has stockholders, ...
... SAN DIEGO , July 30 CareFusion Corporation (NYSE: ... Tuesday, Aug. 10 following the close of trading on the New York Stock Exchange. ... The company will host a webcast and conference ... p.m. Eastern time ) to discuss the results for its fourth quarter and fiscal 2010, ...
Cached Medicine Technology:PharmAthene Provides Update on NYSE Amex Listing Compliance Plan 2PharmAthene Provides Update on NYSE Amex Listing Compliance Plan 3CareFusion Will Host an Earnings Conference Call on Aug. 10 to Discuss the Results for the Fourth Quarter and Fiscal 2010 2
(Date:5/6/2015)... May 06, 2015 The American Water ... period for its prestigious Integrated Water Resources Management (IWRM) ... approach to water resources projects. , An IWRM approach to ... establishment in 1964. In 2014, 12 projects were nominated for ... magazine features not only the 2014 AWRA IWRM Award winner ...
(Date:5/6/2015)... May 06, 2015 Qualidigm ... Conn., has hired healthcare executive Ann Olson, RN, ... Olson will lead Qualidigm’s growing home healthcare services ... to improve the quality, safety, and cost-effectiveness of ... Qualidigm from Interim HealthCare of North Haven, Inc., ...
(Date:5/6/2015)... Novodiax announced today that they will ... with Ed Begley Jr., airing via Discovery Channel ... , This segment will explore Novodiax, a company ... will learn about Novodiax’s polymer detection system-based Direct ... scenes to investigate how, based on this technology, ...
(Date:5/6/2015)... VA (PRWEB) May 06, 2015 The ... CIT GAP Funds has invested in e-Kare, Inc. of ... the assessment and monitoring of chronic wounds. , Chronic ... and complex surgical wounds that affect over 6.5 million ... 2013 as a spin-off enterprise from the Children’s National ...
(Date:5/6/2015)... Stout Industries is owned and operated by Ryan ... fire departments. Stout Industries recently developed Fire-ground Injury Reduction ... these fire safety devices. The departure lights are bright ... on. They light the area within 50 feet of the ... roof, preventing leg and ankle injuries. In 2013 there ...
Breaking Medicine News(10 mins):Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3Health News:Novodiax to Be Featured in Upcoming Episode of Innovations TV Series 2Health News:CIT GAP Funds Invests in e-Kare 2Health News:CIT GAP Funds Invests in e-Kare 3Health News:Kickstarter for FIRE Lights, the New Fire Safety Devices 2
... , , PALATINE, Ill., July 17 Addus ... on Form S-1 with the U.S. Securities and Exchange Commission (SEC) ... The number of shares to be offered and the price ... of the shares in the proposed offering will be offered by ...
... ... Kids (TRACK™) is the first validated, parent-administered asthma-control test for preschool-aged children , ... Wilmington, DE (PRWEB) July ... five simple questions to determine if their child,s breathing problems are not under control. ...
... , WASHINGTON, July 17 The nation,s largest ... of a key amendment in the House Education and Labor ... would enable individual states to go a step farther and ... Introduced by Rep. Dennis Kucinich of Ohio, the ...
... for new treatments, researchers say , FRIDAY, July 17 (HealthDay ... with high blood pressure in black Americans that could hopefully ... risk factor for heart disease and stroke. , Their study, ... Genetics , is one of a series being done to ...
... , Patient Advocates , Medicare ... Oxygen Therapy Act, Oppose Additional Cuts to Oxygen Benefit ... Asking members of Congress to support patient-focused reform of the Medicare ... Emphysema/COPD Association (NECA), a national advocacy organization representing patients with chronic ...
... WORCESTER, Mass., July 17 The Hanover Insurance Group (NYSE: ... today announced the availability of a new product offering that can extend ... , , (Logo: ... The coverage is more important than ever as the population of ...
Cached Medicine News:Health News:Addus HomeCare Corporation Files Registration Statement 2Health News:New Five-Question Test Helps Assess Asthma Control In Children Under Five Years Of Age 2Health News:New Five-Question Test Helps Assess Asthma Control In Children Under Five Years Of Age 3Health News:New Five-Question Test Helps Assess Asthma Control In Children Under Five Years Of Age 4Health News:RNs Praise House Vote to Permit State Single-Payer Laws 2Health News:RNs Praise House Vote to Permit State Single-Payer Laws 3Health News:Five Hypertension Genes Found in Black Americans 2Health News:Five Hypertension Genes Found in Black Americans 3Health News:Home Oxygen Patients and Family Members Visit Capitol Hill to Ask Congress to Protect Medicare Home Oxygen Therapy Benefit 2Health News:The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 2Health News:The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 3
Barraquer needle holder, curved, delicate....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medium weight bone cutter....
Medicine Products: